Curcumin inhibits human cancer cell growth and migration through downregulation of SVCT2

Abstract

Curcumin is a natural polyphenol that is extracted from the rhizomes of the turmeric plant (Curcuma longa), a member of the ginger family. It has been used for centuries in traditional Indian and Chinese medicine for its medicinal properties, including anti‐inflammatory, antioxidant and antitumor effects. SVCT2 (Solute Carrier Family 23 Member 2, also known as SLC23A2) is a protein that plays a role in the transport of Vitamin C (Ascorbic Acid) into cells. SVCT2 plays an important role in tumor progression and metastasis, however, the molecular mechanisms of curcumin on SVCT2 have not been studied to date. Curcumin treatment inhibited proliferation and migration of cancer cells in a dose dependent manner. We found that curcumin reduced the expression of SVCT2 in cancer cells with a wild type p53, but not in those with a mutant type of p53. SVCT2 downregulation also reduced the MMP2 activity. Taken together, our results indicate that curcumin inhibited human cancer cell growth and migration by regulating SVCT2 through a downregulating p53. These findings provide new insights into the molecular mechanisms of curcumin's anticancer effects and potential therapeutic strategies for the treatment of metastatic migration.

Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy

“…These properties encompass antibacterial, antioxidant, anti-inflammatory, anti-proliferative, anti-cancer, and various other beneficial effects. In this part, pertinent studies on several typical TCM natural products that have potential anti-cancer property are expounded in the following paragraphs and summarized in Table 2 ( 39 , 79 , 80 , 82 – 124 , 132 ). Additionally, some closed and ongoing national clinical trials (NCT) on the association between TCMs and multiple cancer types are also displayed in Table 3 .…”